Portola Pharmaceuticals Inc is a biopharmaceutical company that develops & commercializes novel therapeutics in the areas of thrombosis other hematologic disorders & inflammation for patients who currently have limited or no approved treatment options.


Updates from The Motley Fool

Latest updates on Portola Pharmaceuticals from Fool.com.  The Fool has written over 100 articles on Portola Pharmaceuticals.
3 Hot Stocks to Buy in April

Dexcom, Shopify, and Portola Pharmaceuticals have been on an absolute tear in 2017. Here's why sh...

2 Top Stocks in Biotech

An increasingly strict FDA has made these great biotech stocks even more attractive than usual.

3 Stocks That Could Make You Rich

If you have an appetite for risk, these stocks could provide huge gains in a relatively short per...



Stock Performance

View Interactive PTLA Charts
Sponsored by

Key Data Points

Primary metrics and data points about Portola Pharmaceuticals.
Current Price: $39.99
Prev Close: $39.64
Open: $39.64
Bid: $39.15
Ask: $40.90
Day's Range: $39.11 - $40.14
52wk Range: $15.68 - $41.27
Volume: 600,528
Avg Vol 786,211
Market Cap: $2B
P/E (ttm): -8.33
EPS (ttm): ($4.76)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Portola Pharmaceuticals.
CAPS Rating 5 out of 5
 
87 Outperform
0 Underperform
CAPS All Stars
 
18 Outperform
0 Underperform

How do you think Portola Pharmaceuticals will perform against the market?



You pick for Portola Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Portola Pharmaceuticals.

Portola Pharmaceuticals Inc is a biopharmaceutical company that develops & commercializes novel therapeutics in the areas of thrombosis other hematologic disorders & inflammation for patients who currently have limited or no approved treatment options.

  • Exchange: NASDAQ